Literature DB >> 6968540

Synergistic action of ampicillin and nafcillin against ampicillin-resistant Haemophilus influenzae.

R Yogev, E Burkholder, A T Davis.   

Abstract

Six strains of ampicillin-resistant Haemophilus influenzae type b were studied in vitro for synergy between ampicillin and nafcillin. The minimal inhibitory concentrations for these strains with 10(4) colony-forming units per ml were 6.25 to 12.5 microgram of ampicillin per ml and 6.25 to 25 microgram of nafcillin per ml. Studies with these agents demonstrated synergism against all six strains of H. influenzae type b. Most strains were inhibited by 0.78 microgram of nafcillin plus 0.78 microgram of ampicillin per ml. A child with osteomyelitis caused by H. influenzae type b was successfully treated with a combination of ampicillin and nafcillin. These data suggest that further studies assessing the synergistic effect of this drug combination against H. influenzae type b are warranted.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 6968540      PMCID: PMC283809          DOI: 10.1128/AAC.17.3.461

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  12 in total

1.  Susceptibility of Haemophilus influenza to ampicillin as determined by use of a modified, one-minute beta-lactamase test.

Authors:  J Escamilla
Journal:  Antimicrob Agents Chemother       Date:  1976-01       Impact factor: 5.191

2.  SYNERGISTIC ACTION OF PENICILLINS AND CEPHALOSPORINS AGAINST PSEUDOMONAS PYOCYANEA.

Authors:  L D SABATH; E P ABRAHAM
Journal:  Nature       Date:  1964-12-12       Impact factor: 49.962

3.  Meningitis due to chloramphenicol-resistant Haemophilus influenzae type b.

Authors:  A L Kinmonth; C N Storrs; R G Mitchell
Journal:  Br Med J       Date:  1978-03-18

4.  Haemophilus influenzae type B resistant to ampicillin. A report of two cases.

Authors:  W Khan; S Ross; W Rodriguez; G Controni; A K Saz
Journal:  JAMA       Date:  1974-07-15       Impact factor: 56.272

5.  Letter: Ampicillin-resistant Haemophilus influenzae meningitis.

Authors:  W J Thomas; J W McReynolds; C R Mock; D W Bailey
Journal:  Lancet       Date:  1974-02-23       Impact factor: 79.321

6.  Beta-lactamase effect on ampicillin treatment of Haemophilus influenzae B bacteremia and meningitis in infant rats.

Authors:  E R Moxon; A A Medeiros; T F O'Brien
Journal:  Antimicrob Agents Chemother       Date:  1977-10       Impact factor: 5.191

7.  Chloramphenicol resistance in Haemophilus influenzae.

Authors:  A Manten; B van Klingeren; M Dessens-Kroon
Journal:  Lancet       Date:  1976-03-27       Impact factor: 79.321

8.  Clinical and pharmacokinetic evaluation of nafcillin in infants and children.

Authors:  W E Feldman; J D Nelson; L R Stanberry
Journal:  J Pediatr       Date:  1978-12       Impact factor: 4.406

9.  Treatment of ampicillin-resistant Haemophilus influenzae in soft tissue infections with high doses of ampicillin.

Authors:  D Murphy; J Todd
Journal:  J Pediatr       Date:  1979-06       Impact factor: 4.406

10.  Effect of beta-lactamase location in Escherichia coli on penicillin synergy.

Authors:  H C Neu
Journal:  Appl Microbiol       Date:  1969-06
View more
  3 in total

1.  In vitro and in vivo synergism between amoxicillin and clavulanic acid against ampicillin-resistant Haemophilus influenzae type b.

Authors:  R Yogev; C Melick; W J Kabat
Journal:  Antimicrob Agents Chemother       Date:  1981-06       Impact factor: 5.191

2.  Comparative in vitro and in vivo activity of temocillin (BRL 17421) and ampicillin against Haemophilus influenzae type b.

Authors:  R Yogev; W Glogowski; E Connor
Journal:  Antimicrob Agents Chemother       Date:  1983-01       Impact factor: 5.191

3.  Synergistic action of nafcillin and ampicillin against ampicillin-resistant Haemophilus influenzae type b bacteremia and meningitis in infant rats.

Authors:  R Yogev; W J Kabat
Journal:  Antimicrob Agents Chemother       Date:  1980-07       Impact factor: 5.191

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.